These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25524393)

  • 1. Metabolic abnormalities among people diagnosed with schizophrenia: a literature review and implications for mental health nurses.
    McDaid TM; Smyth S
    J Psychiatr Ment Health Nurs; 2015 Apr; 22(3):157-70. PubMed ID: 25524393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Drawing up guidelines for the attendance of physical health of patients with severe mental illness].
    Saravane D; Feve B; Frances Y; Corruble E; Lancon C; Chanson P; Maison P; Terra JL; Azorin JM;
    Encephale; 2009 Sep; 35(4):330-9. PubMed ID: 19748369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nursing care of clients treated with atypical antipsychotics who have a risk of developing metabolic instability and/or type 2 diabetes.
    Edward KL; Rasmussen B; Munro I
    Arch Psychiatr Nurs; 2010 Feb; 24(1):46-53. PubMed ID: 20117688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and obsessive-compulsive disorder: a naturalistic Italian study.
    Albert U; Aguglia A; Chiarle A; Bogetto F; Maina G
    Gen Hosp Psychiatry; 2013; 35(2):154-9. PubMed ID: 23158675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A two fold risk of metabolic syndrome in a sample of patients with schizophrenia: do consanguinity and family history increase risk?
    Bener A; Al-Hamaq AO; Dafeeah EE
    Diabetes Metab Syndr; 2014; 8(1):24-9. PubMed ID: 24661754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metabolic syndrome in untreated schizophrenia patients: prevalence and putative mechanisms.
    Reddy SM; Goudie CT; Agius M
    Psychiatr Danub; 2013 Sep; 25 Suppl 2():S94-8. PubMed ID: 23995153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Description of a healthy lifestyle intervention for people with serious mental illness taking second-generation antipsychotics.
    Park T; Usher K; Foster K
    Int J Ment Health Nurs; 2011 Dec; 20(6):428-37. PubMed ID: 21564457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comorbidity of metabolic syndrome, diabetes and schizophrenia: theoretical and practical considerations].
    Réthelyi J; Sawalhe AD
    Orv Hetil; 2011 Mar; 152(13):505-11. PubMed ID: 21398211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity and metabolic syndrome in a psychiatric rehabilitation service.
    Tirupati S; Chua LE
    Aust N Z J Psychiatry; 2007 Jul; 41(7):606-10. PubMed ID: 17558623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome among psychiatric inpatients with schizophrenia in Indonesia.
    Marthoenis M; Aichberger MC; Puteh I; Syahrial S; Schouler-Ocak M
    Asian J Psychiatr; 2015 Jun; 15():10-4. PubMed ID: 25910596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic screening for metabolic syndrome in consumers with severe mental illness.
    Brunero S; Lamont S
    Int J Ment Health Nurs; 2009 Apr; 18(2):144-50. PubMed ID: 19290978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What support can community mental health nurses deliver to carers of people diagnosed with schizophrenia? Findings from a review of the literature.
    Macleod SH; Elliott L; Brown R
    Int J Nurs Stud; 2011 Jan; 48(1):100-20. PubMed ID: 20956000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome in patients with psychotic disorders: diagnostic issues, comorbidity and side effects of antipsychotics.
    Kozumplik O; Uzun S; Jakovljević M
    Psychiatr Danub; 2010 Mar; 22(1):69-74. PubMed ID: 20305594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimising metabolic and cardiovascular risk in schizophrenia: diabetes, obesity and dyslipidaemia.
    Barnett AH; Mackin P; Chaudhry I; Farooqi A; Gadsby R; Heald A; Hill J; Millar H; Peveler R; Rees A; Singh V; Taylor D; Vora J; Jones PB
    J Psychopharmacol; 2007 Jun; 21(4):357-73. PubMed ID: 17656425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of antipsychotic medication on metabolic syndrome.
    Jones M; Jones A
    Nurs Stand; 2008 Aug 6-12; 22(48):43-8. PubMed ID: 18727355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of metabolic syndrome among patients with schizophrenia in Japan.
    Sugawara N; Yasui-Furukori N; Sato Y; Umeda T; Kishida I; Yamashita H; Saito M; Furukori H; Nakagami T; Hatakeyama M; Nakaji S; Kaneko S
    Schizophr Res; 2010 Nov; 123(2-3):244-50. PubMed ID: 20850274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The physical health of people with schizophrenia in Asia: Baseline findings from a physical health check programme.
    Thongsai S; Gray R; Bressington D
    J Psychiatr Ment Health Nurs; 2016 Jun; 23(5):255-66. PubMed ID: 27090192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome in schizophrenia: Differences between antipsychotic-naïve and treated patients.
    Chadda RK; Ramshankar P; Deb KS; Sood M
    J Pharmacol Pharmacother; 2013 Jul; 4(3):176-86. PubMed ID: 23960422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic complications of schizophrenia and antipsychotic medications--an updated review.
    Yogaratnam J; Biswas N; Vadivel R; Jacob R
    East Asian Arch Psychiatry; 2013 Mar; 23(1):21-8. PubMed ID: 23535629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and associated cardiovascular risk factors in the treatment of persons with human immunodeficiency virus and severe mental illness.
    Vergara-Rodriguez P; Vibhakar S; Watts J
    Pharmacol Ther; 2009 Dec; 124(3):269-78. PubMed ID: 19647020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.